Please click here to access the latest WiL Newsletter
Women in Lymphoma is honoured to have been invited to contribute ten manuscripts for a special WiL edition of Hematological Oncology.
Here are links to the manuscripts:
Women in Lymphoma: A 4-year journey in promoting gender equity
Invited Perspective - Open Access
https://onlinelibrary.wiley.com/doi/10.1002/hon.3183
Career development: A balance of opportunities and choices
Invited Perspective - Open Access
https://onlinelibrary.wiley.com/doi/10.1002/hon.3193
(Re)Minding the obvious
Commentary
https://onlinelibrary.wiley.com/doi/10.1002/hon.3182
Cellular Therapy in Lymphoma
Review
https://onlinelibrary.wiley.com/doi/10.1002/hon.3200
Brain Lymphoma – assessment, treatment and prevention of CNS relapse
Invited Review
https://onlinelibrary.wiley.com/doi/10.1002/hon.3197
Latest updates in nodal peripheral T-cell lymphoma
Review
https://onlinelibrary.wiley.com/doi/abs/10.1002/hon.3191
Classic Hodgkin Lymphoma
https://onlinelibrary.wiley.com/doi/10.1002/hon.3239
Personalised therapy in follicular lymphoma – is the dial turning?
Invited Review - Open Access
https://onlinelibrary.wiley.com/doi/10.1002/hon.3205#
Diffuse Large B-cell Lymphoma
Invited Review - Open Access
https://onlinelibrary.wiley.com/doi/10.1002/hon.3202
Recent updates in the indolent lymphomas: Update on Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia
Review - Open Access
https://onlinelibrary.wiley.com/doi/10.1002/hon.3210
Women in Lymphoma is very thankful for the generous sponsorship from industry supporters around the world including Gilead Kite.
**WiLing Wednesdays educational webinars hosted by Women in Lymphoma are solely intended for professionals working in the field of lymphoma. All patients seeking guidance or support with a lymphoma diagnosis or treatment are advised to consult their specialist haematologist**
WiLing Wednesdays live webinar educational series recording links are available here:
SERIES 12 - HODGKIN LYMPHOMA - May/June 2024
Session 1 - Strategies to Tailor Treatment for Hodgkin Lymphoma
Session 2 - Global Perspectives on Treatment of Newly Diagnosed and Relapsed/Refractory Hodgkin Lymphoma with a Focus on Advanced Stage
Session 3 - Current/Forthcoming Clinical Trials in Hodgkin Lymphoma
Session 4 - Nodular Lymphoma Predominant Hodgkin Lymphoma and Other Pathologic Phenomena in Hodgkin Lymphoma
SERIES 11 – DLBCL - March/April 2024
Session 1 - Upfront DLBCL Therapy
Session 2 - The Changing Algorithm in R/R DLBCL
Session 3 - Expanding Novel Therapies in R/R DLBCL
Session 4 - Tailoring Therapy in R/R DLBCL
Session 5 - Update on DLBCL Classification
SERIES 10 – CAREER DEVELOPMENT - October/November 2023
Session 1 - Navigating early career development: Mentorship and Academic Promotion
https://vimeo.com/manage/videos/878157032
Session 2 - Tips & Pearls for Publishing Success
Session 3 - Identifying and Pursuing Research Opportunities and Cooperative work
Session 4 - Making Meaning in the Second half of your Career – leadership planning and new experiences
SERIES 9 – MANTLE CELL LYMPHOMA (MCL) - May 2023
Session 1 - MCL Treatment
Session 2 - MCL Prognostication
Session 3 - Pathogenesis & Biology
SERIES 8 – CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL) - February/March 2023
Session 1 - CLL frontline treatment/new drugs/global access
Session 2 - Tough CLL
Session 3 - Career Development
Session 4 - Optimal Investigation of CLL - molecular studies, risk stratification & MRD
SERIES 7 - LYMPHOMA & THE BRAIN - September/October 2022
Session 1 - PCSNL - Diagnosis and Treatment
Session 2 - PSNSL - Elderly and side effects
SESSION 3 - SCNSL and CAR-T
SESSION 4 - Debate on CNS Prophylaxis
SESSION 5 - Other brain lymphomas & imaging
SERIES 6 - CELLULAR THERAPY - April/May 2022
SESSION 1 - Defining Cellular Therapies
SESSION 2 - CAR-T Cells in different clinical settings - Treatment of DLBCL/Treatment of FL, MCL, CLL
SESSION 3 - Moving forward in CAR-T Cell - Mechanisms of Resistance/Modified CAR-T Strategies – Allo CAR-T, Dual CAR-T
SESSION 4 - CAR-T Strategies vs. BiTes
SESSION 5 - Global discussion on access, application, real-life experiences & challenges
SERIES 5 - CAREER DEVELOPMENT - Part 1 - March/April 2022
Session 1 - APPs
Session 2 - Legendary WiL
SERIES 4 – INDOLENT LYMPHOMA - October/November 3, 2021
Session 1 - Living with Follicular Lymphoma/Follicular Lymphoma pathogenesis and clonal evolution, transformed FL
Session 2 - Risk stratification in Follicular Lymphoma/Utility of PET in Follicular Lymphoma
Session 3 - Advances for treatment for Follicular Lymphoma/Treatment paradigms for relapsed and refractory Follicular Lymphoma
Session 4A - Career Development with Change Champions and their Mentees
Session 4B - Career Development with Change Champions and their Mentees
Session 5 - Treatment options in Marginal Zone Lymphoma/Waldenstrom’s Macroglobulinemia
SERIES 3 - T-CELL LYMPHOMA - April/May 2021
Session 1 - Update on T-cell : Lymphoma HemPath review/Primary therapy of common peripheral T-cell lymphoma
Session 2 - HemPath review of T-cell lymphomas common in Asia/Frontline & Salvage therapies for T-cell lymphomas common in Asia
Session 3 - Treatment & outcome for relapsed T-cell lymphomas/Use of autologous & allogenuc transplant for T-cell lymphomas
Session 4 - Newer therapies & Clinical trials for T-cell lymphomas/Case studies of T-cell lymphomas
Session 5 - Career Development
SERIES 2 - HODGKIN LYMPHOMA - January/February 2021
https://www.youtube.com/@womeninlymphoma
SERIES 1 - DLBCL - September 2020
Recordings are not available unfortunately.
Copyright © 2024 Women in Lymphoma - All Rights Reserved.
Powered by GoDaddy Website Builder